OIS Podcast Ep

In our latest episode, host Dr. Rob Rothman interviews Greg Kunst, CEO of Aurion Biotech, to delve into the forefront of cell therapy for corneal disease. Join us to discover:

🔹Greg's journey from pivotal roles at Alcon and Glaukos to leading Aurion Biotech
🔹The innovative allogenic cell therapy technology developed by Aurion
🔹How this technology addresses the global shortage of corneal tissue
🔹Insights into the challenges and breakthroughs in scaling production and securing market approval
🔹Future applications of cell therapy in ophthalmology beyond corneal endothelial disease

Don't miss this fascinating conversation on the future of medical innovation in ophthalmology! Listen to the episode and subscribe to the OIS Podcast for more updates on the latest trends in eye care and medical technology.

Website:
https://ois.net

FOLLOW Ophthalmology Innovation Source On Social Media:
► LinkedIn:   / ois-net  
► Twitter:   / oistweets  

JOIN Our Group For Ophthalmology Innovation & Investment On LinkedIn
  / 2189664  

SUBSCRIBE To Our Weekly OIS Newsletter
http://bit.ly/2yFOXUt

VIEW Our Past Ophthalmology Event Conferences:
https://ois.net/past-events

REGISTER For Our Next Meeting:
https://ois.net/ois-events/

#OIS #Ophthalmology #Healthcare #Ophthalmic #Medicalinnovation #Retina #Eyediseases

_________________________________________________________________

About OIS

Ophthalmology Innovation Summit (OIS) facilitates meaningful interactions and the exchange of information between clinical, capital, and corporate leaders to accelerate the development and commercialization of novel therapies to address unmet needs.

Since 2009, the Ophthalmology Innovation Summit programs are independently produced conferences presented annually by Healthegy, Inc.